Through this partnership, Akili and Roblox are introducing new ways for medicine to fit into patients' lives.
Data from the study show that EndeavorRx treatment resulted in increased brain activity related to attention function, as measured by EEG.
The enhancements were based on the latest trends in video game development and informed by user insights collected across multiple forums.
The STARS-ADHD trial will evaluate the safety and efficacy of the company's proprietary platform, Project: EVO, for the treatment of children with ADHD.
The company will use the funds to support further development of its product, prepare for a potential FDA clearance, and eventually launch in 2017.
Developed by Akili Interactive Labs, Project: EVO was designed to assess and treat cognitive issues; it adapts the intensity of the game to the player.
The trial will look to measure cognitive and symptom improvement over one month of device play; recruitment will begin toward the end of the year.